… Study Evaluating the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) of a novel high-affinity, long-acting anti-IgE antibody (LP-003) in healthy volunteers
用户qnD1A9QABeHo
3小时前
9
10
待确认
帖子自动结束时间: 2025-04-27 15:15:09
1. 请及时下载文件确认是否正确, 系统将在 2025-04-29 15:36:21 删除文件
2. 如若文件有误请驳回应助文件, 求助状态即回到求助中
3. 如若文件正确请及时点击确认, 若超过时后系统自动默认为已完结
注: 所有应助的资源仅供学习交流使用, 不得违反相关法律法规
DOI:
文献链接:
其他信息:
Y Zhi, N Sun, CR Zhou, H Yang, R Guo, H Ma…
Journal of the American …, 2024
jaad.org
… LP-003 appears to show good safety profile. No Grade 3 and above TEAE was reported. … phase I study of LP-003 suggests that this novel high affinity and long-acting anti-IgE antibody …